The field of peptide treatment is experiencing a remarkable shift with the rise of AMP (Accelerated Molecule Peptide) chains. These innovative compounds are engineered to rapidly cross biological boundaries, offering the potential for enhanced drug distribution and targeted therapeutic action . Earl